Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib Whi-An KwonIn-Chang ChoJinsoo Chung Urologic Oncology 01 October 2013 Pages: 4397 - 4404